Company: GANX
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001558370-25-011220
Chunk: 17

Company: Gain Therapeutics, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part II, Item 6
Chunk 17
---
Item 6. Exhibits.

​​​​Incorporated by ReferenceExhibit No.    Exhibit Description    Form    File No.    Exhibit    Filing Date3.1​Amended and Restated Certificate of Incorporation of Gain Therapeutics, Inc.​8-K​001-40237​3.1​3/17/20213.2​Amended and Restated Bylaws of Gain Therapeutics, Inc.​8-K​001-40237​3.2​3/17/20213.3​Certificate of Amendment of Amended and Restated Certificate of Incorporation of Gain Therapeutics, Inc., filed with the Secretary of State of the State of Delaware on June 24, 2025.​8-K​001-40237​3.1​6/24/20254.1​Form of Warrant​8-K​001-40237​4.1​7/17/20254.2​Form of Underwriter’s Warrant​8-K​001-40237​4.2​7/17/20254.3​Form of Warrant Agent Agreement, by and between Gain Therapeutics, Inc. and Pacific Stock Transfer Company​8-K​001-40237​4.3​7/17/202531.1*​Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.​​​​​​​​31.2*​Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.​​​​​​​​32.1†​Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.​​​​​​​​101.INS*​Inline XBRL Instance Document​​​​​​​​101.SCH*​Inline XBRL Taxonomy Extension Schema Document​​​​​​​​101.CAL*​Inline XBRL Taxonomy Extension Calculation Linkbase Document​​​​​​​​101.DEF*​Inline XBRL Taxonomy Extension Definition Link